Page last updated: 2024-08-24

web 2086 and tcv 309

web 2086 has been researched along with tcv 309 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Imura, Y; Kawamura, M; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S	1
Imura, Y; Maezaki, N; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S	1

Other Studies

2 other study(ies) available for web 2086 and tcv 309

Article	Year
Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:2 Topics: Anaphylaxis; Animals; Azepines; Furans; Hemolysis; Humans; Hypotension; Isoquinolines; Male; Microsomes; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Shock, Septic; Tetrahydroisoquinolines; Triazoles	1992
Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309. Advances in prostaglandin, thromboxane, and leukotriene research, 1991, Volume: 21B Topics: Animals; Azepines; Humans; Isoquinolines; Molecular Structure; Niacinamide; Platelet Activating Factor; Pyridinium Compounds; Rabbits; Rats; Structure-Activity Relationship; Tetrahydroisoquinolines; Triazoles	1991

Article

Year

Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.

The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:2

Topics: Anaphylaxis; Animals; Azepines; Furans; Hemolysis; Humans; Hypotension; Isoquinolines; Male; Microsomes; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Shock, Septic; Tetrahydroisoquinolines; Triazoles

1992

Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.

Advances in prostaglandin, thromboxane, and leukotriene research, 1991, Volume: 21B

Topics: Animals; Azepines; Humans; Isoquinolines; Molecular Structure; Niacinamide; Platelet Activating Factor; Pyridinium Compounds; Rabbits; Rats; Structure-Activity Relationship; Tetrahydroisoquinolines; Triazoles

1991